期刊文献+

复合rhBMP-2的注射型成骨材料修复犬桡骨骨缺损的实验研究 被引量:1

Experimental Investigations of the Injectable Osteoinductive Material with Fibrin Sealant as a Carrier in Repairing the Segmental Dog Radius Defects
下载PDF
导出
摘要 探讨以纤维蛋白胶(fibrin sealant,FS)为载体,复合rhBMP-2\bFGF的注射型骨修复材料,修复犬桡骨节段性缺损的作用,为其临床应用提供实验依据。实验分为:实验组(FS+bFGF+rhBMP-2)、对照组(FS)。于12只成年健康家犬右侧桡骨中上段造成2cm缺损,制成犬桡骨2cm骨缺损实验模型,然后严密缝合皮下组织及皮肤,将实验材料经伤口周围正常皮肤注射到骨缺损处,术后4、8、16、24w进行放射学检查,术后24w,标本进行组织学和骨密度检查,研究其成骨效应。结果表明:实验组骨缺损区在成骨活跃程度、骨密度和再生髓腔结构等方面均显著优于对照组,使骨缺损得到了成功的修复(P<0.01)。以纤维蛋白胶为载体复合rhBMP-2和bFGF的注射型骨修复材料,具有高效的骨修复能力,对犬的骨缺损有很好的修复效果。 To investigate the effect of the injectable osteoinductive material with Fibrin sealant as a carrier compounded with rhBMP-2 and bFGF in repairing the segmental dog radius defects and provide experimental foundation for the clinical application in the future.2cm bone defects were created in the 12 dog radii,and the composites of experiment group(FS+bFGF+rhBMP-2)and control group(FS) were percutaneously injected into the defects after primary injuries respectively.The effect of repairing the segmental dog radiuls ′defects was evaluated by radiography,histology,bone mineral density(BMD) in4,8,16,24 weeks after operation.Results showed that in the experimental groups with rhBMP-2 as osteoinductive factor,repairing capability and rate of osteogenesis in experiment group(FS+bFGF+rhBMP-2) was significantly higher than that in control group(FS)(P<0.01.) The bone defects of the experimental group were healed in 8 weeks after operation.The injectable osteoinductive material with fibrin sealant as a carrier compounded with rhBMP-2 and bFGF has effective repairing ability to the dog radius′s defects.
出处 《生物医学工程研究》 2006年第4期251-254,共4页 Journal Of Biomedical Engineering Research
关键词 纤维蛋白胶 骨形态发生蛋白 碱性成纤维细胞生长因子 载体 Fibrin sealant Bone morphogenic protein Basic fibroblast growth factor Carrier
  • 相关文献

参考文献16

二级参考文献15

  • 1丁真奇,谭富生,吴祖尧,曹本珍,蒋电明.四种移植材料修复兔颅骨缺损的比较研究[J].中华创伤杂志,1994,10(6):261-263. 被引量:61
  • 2李亚非,胡蕴玉,吕荣,王纪保.四种可溶性载体对骨形态发生蛋白在小鼠体内诱导成骨活性的影响[J].中华骨科杂志,1997,17(2):117-119. 被引量:25
  • 3刘金刚,低温医学,1993年,79页
  • 4罗明生,药剂辅料大全,1993年,805页
  • 5柏乃庆,人体保存.细胞、组织和器官的保存技术,1985年,303页
  • 6李亚非,中华骨科杂志,1996年,16卷,53页
  • 7白孟海,中华骨科杂志,1995年,15卷,20页
  • 8Radosevich M,Goubran HI,Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. [J].Vox Sang, 1997,72(3):133~143
  • 9Gospodarowicz D. Fibroblast growth factor: Chemical structure and biological function[J].Clin Orthop, 1990, 257: 231~234.
  • 10Yamaguchi A. Recent advances in researches on bone formation-role of BMP in bone formation[J].Nippon Rinsho,1998,56(6):1406~1411.

共引文献127

同被引文献11

  • 1李亚非,胡蕴玉,吕荣,王纪保.四种可溶性载体对骨形态发生蛋白在小鼠体内诱导成骨活性的影响[J].中华骨科杂志,1997,17(2):117-119. 被引量:25
  • 2[2]Hattori T.Experimental investigations of osteogenesis and chondrogenesis by implant of BMP-fibrin glue mixture[J].Nippon Seikeigeka Gakkai Zasshi,1990,64(9):824-34.
  • 3[3]Kawamura M,Urist MR.Human fibrin is a physiologic delivery system for bone morphogenetic protein[J].Clin Orthop,1988,235:302-310.
  • 4[6]Kim NH,Yang KH,Lee HM,et al.Effect of porcine bone morphogenetic protein on healing of bone defect in the rabbit radius[J].Yonsei Med J,1992,33(1):54-63.
  • 5[7]Radosevich M,Goubran HI,Burnouf T.Fibrin sealant:scientific rationale,production methods,properties,and current clinical use[J].Vox Sang,1997,72(3):133-143.
  • 6[8]Reiss RF,Oz MC.Autologous fibrin glue:production and clinical use[J].Transfus Med Rev,1996,10(2):85-92.
  • 7[9]Gregory R,Mundy MD.Regulation of bone formation by bone morphogenetic proteins and other growth factors[J].Clin Orthop and Related Res,1996,323:2437.
  • 8[11]Sherma S,Garg NK,Veliath AJ,et al.Percataneous bone-marrow grafting of osteotomies and bony defects in rabbits[J].Acta Orthop Scand,1992,63(2):166.
  • 9陈克明,刘兴炎,葛宝丰,李旭升,王艳宁,白孟海,王勇.纤维蛋白用作BMP载体的研究[J].中华骨科杂志,1998,18(4):234-235. 被引量:29
  • 10郑正庭,马平,吕荣,王军.经皮注射骨形态发生蛋白和自体红骨髓修复兔骨缺损与骨不连[J].第四军医大学学报,1999,20(8):726-729. 被引量:10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部